Add Company
Join Now

Ganymed Pharmaceuticals Revenue and Competitors

License our Company Data API

Mainz,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Ganymed Pharmaceuticals's estimated annual revenue is currently $2.3M per year.(i)
  • Ganymed Pharmaceuticals's estimated revenue per employee is $155,000

Employee Data

  • Ganymed Pharmaceuticals has 15 Employees.(i)
  • Ganymed Pharmaceuticals grew their employee count by 0% last year.

Ganymed Pharmaceuticals's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$99.4M45840%N/AN/A
#2
$20.6M13322%N/AN/A
#3
$156.1M146-70%$145MN/A
#4
$3.5M45-25%$150MN/A
#5
$1.6M210%$459.5MN/A
#6
$67.3M31016%$180.7MN/A
#7
$8.5M55-2%N/AN/A
#8
$256.3M10259%$168.5MN/A
#9
$2.8M18-33%N/AN/A
#10
$9.1M59-9%N/AN/A
Add Company

What Is Ganymed Pharmaceuticals?

GANYMED Pharmaceuticals AG is a biotechnology company based out of 12Freiligrathstraße, Mainz, Rhineland-Palatinate, Germany.

keywords:N/A

N/A

Total Funding

15

Number of Employees

$2.3M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Ganymed Pharmaceuticals News

2022-04-13 - Bispecific Antibody Market to Reach 810.4 Million, Globally, by ...

These pharma companies which are involved in the drug development have a strong ... Paktis Antibody Services GmBH; Ganymed Pharmaceuticals...

2022-04-06 - Bispecific Antibody Market Outlook: Post Covid-19 Scenario ...

... Post Covid-19 Scenario by 2028 | Oncomed Pharmaceuticals, Abbvie, ... Inc., Paktis Antibody Services GmBH, Ganymed Pharmaceuticals,...

2022-03-30 - AstraZeneca bets $25M on preclinical bispecific against hot ...

... the Big Pharma has landed worldwide rights to Harbour BioMed's (HBM's) ... euros ($459 million) to buy Ganymed Pharmaceuticals for its anti-CLDN18.2...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.8M167%N/A
#2
$1.5M170%N/A
#3
$2.8M20-5%N/A
#4
$9.4M3633%N/A
#5
$6.2M3719%$14M